Health
Access to cancer medicines and clinical trials show stark variations across Europe – Medical Xpress
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to resul…
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to results from studies presented at ESMO 2020.
Countries in Western Europe run a higher number of clinical trials for novel cancer treatments than countries in Eastern and Central Europe, showed an analysis of clinical trials active in different c…
-
Noosa News15 hours agoProtest calls for shark net removal
-
Noosa News16 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General14 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News7 hours agoYork family honours late son with tractor museum to fund cancer research